Planet 13 Holdings (PLNH) Cost of Revenue (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Cost of Revenue of $11.7 million for Q1 2026, down 27.12% year-over-year from $16.0 million in Q1 2025, and up 8657.21% quarter-over-quarter from $133360.0 in Q4 2025.
Planet 13 Holdings (PLNH) Cost of Revenue (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Cost of Revenue for 6 consecutive years, with $11.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue fell 27.12% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $12.2 million (down 74.95% YoY), while the FY2025 annual figure was $870288.0, down 98.56% from the prior year.
- Cost of Revenue climbed to $11.7 million in Q1 2026 per PLNH's latest filing, from $133360.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $17.2 million in Q4 2024 and bottomed at $99117.0 in Q2 2024.
- Historically, Cost of Revenue has averaged $6.1 million across 5 years, with a median of $408404.0 in 2023.
- Annual changes were most pronounced in 2024 — Cost of Revenue plunged 99.29% — and 2025, when it jumped 6554.06%.
- Planet 13 Holdings' Cost of Revenue stood at $14.2 million in 2022, then sank by 96.87% to $443500.0 in 2023, then soared by 3776.2% to $17.2 million in 2024, then plunged by 99.22% to $133360.0 in 2025, then surged by 8657.21% to $11.7 million in 2026.
- Business Quant data shows PLNH's Cost of Revenue at $11.7 million in Q1 2026, $133360.0 in Q4 2025, and $200787.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Planet 13 Holdings | 46.72 Mn | 30.24 Mn | 12.32 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.54 Mn |
| Jun 30, 2026 | 10.54 Mn |
| Mar 31, 2026 | 11.68 Mn |
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | 133,360.00 |
| Dec 31, 2025 | 133,360.00 |
| Sep 30, 2025 | 200,787.00 |
| Sep 30, 2025 | 200,787.00 |
| Jun 30, 2025 | 206,544.00 |
| Jun 30, 2025 | 206,544.00 |
| Mar 31, 2025 | 16.02 Mn |
| Mar 31, 2025 | 16.02 Mn |
| Dec 31, 2024 | 17.19 Mn |
| Dec 31, 2024 | 17.19 Mn |
| Sep 30, 2024 | 15.46 Mn |
| Sep 30, 2024 | 15.46 Mn |
| Jun 30, 2024 | 99,117.00 |
| Jun 30, 2024 | 99,117.00 |
| Mar 31, 2024 | 240,820.00 |
| Mar 31, 2024 | 240,820.00 |